Category Archives: Post graduate

FDA approves first buprenorphine implant for treatment of opioid dependence

Buprenorphine is a semisynthetic opioid derivative of thebaine. It is a mixed partial agonist opioid receptor modulator that is used to treat opioid addiction in higher dosages, to control moderate acute pain in non-opioid-tolerant individuals in lower dosages and to control moderate chronic pain in even smaller doses.[3] It is available in a variety of […]

FDA Warns About New Impulse-control Problems

Aripiprazole (Abilify, Abilify Maintena, Aristada): Drug Safety Communication – FDA Warns About New Impulse-control Problems [Posted 05/03/2016] AUDIENCE: Psychiatry, Internal Medicine, Patient ISSUE: FDA is warning that compulsive or uncontrollable urges to gamble, binge eat, shop, and have sex have been reported with the use of the antipsychotic drug aripiprazole (Abilify, Abilify Maintena, Aristada, and […]

Maslow Hierarchy for self actualization –هرمية ماسلو لتحقيق الذات –

 وضع ابراهام ماسلو نظرية ارتقاء و نمو النفس الى تحقيق الذات و لم يضع تعريفا دقيقا لتحقيق الذات و لكنه للتبسيط و على وجه العموم هو ان  تصل لمرحلة تبسط فيها رأيك و فكرتك في الوقت الذي تراه بالشكل الذي تراه أمام من تراه  و و تدافع عن فكرتك وتضحى من أجلها و و تبذل الغالي […]

The Latest Antidepressants:

“Must Know” Information About Vilazodone (Viibryd®), Levomilnacipran (Fetzima®), Vortioxetine (Brintellix®), recently introduced, has a specific action improves cognitive functions. It should be titrated 5 ,10 , 15 and 20 mg at morning time for sometimes intolerable nausea. ! amphetamine like action. and Lurasidone (Latuda®)

Diagnosing bipolar disorder

Many patients with borderline personality disorder or other forms of moodiness are wrongly diagnosed as having bipolar disorder. On the other hand, it is simultaneously true that many patients with bipolar disorder (especially bipolar II disorder) continue to be misdiagnosed as having a depressive disorder. Because the treatment of depression and of bipolar disorder is very […]

sub-typing of depression in clinical settings

Dr. Adel Serag is a senior consultant psychiatrist in Fakeeh hospital and Senior Consultant and fellow of psychiatry , Institute of psychiatry, Ain Shams University. A review lecture about the sub-typing of depression and how this will affect positively in clinical description and hence probably the medication. The lecture was given April 2015 during 11th […]

Problems of Mental illness Stigma and co-morbidity

Norman Sartorius, M.D., M.A., D.P.M., Ph.D., FRC. Psych. Dr Norman Sartorius, MD, MA, DPM, PhD, FRCPsych, obtained his M.D. in Zagreb (Croatia). He specialized in neurology and psychiatry and subsequently obtained a Masters Degree and a Doctorate in psychology (Ph.D.). He carried out clinical work and research and taught at graduate and postgraduate levels at […]

Long term treatment of Schizophrenia: Dr. Mohamed Swuidan

Dr. Mohammad Alsuwaidan is an assistant professor of psychiatry at both Kuwait University and the University of Toronto, where he is cross-appointed to the divisions of Brain Therapeutics and Philosophy, Humanities and Educational Scholarship. He is the Founding Director of the Mood & Anxiety Disorders Program at Mubarak Al-Kabeer Hospital.     Research review of […]

Translational Psychiatry from bench to side bed

Translational Psychiatry from bench to side bed Translational Psychiatry from bench to side bed, a lecture given by Prof. Dr. Afaf Hamed , April 2015, In I11th Psychiatricinternational congress in Jeddah Afaf Hamed Khalil Current Post Professor of Psychiatry, Faculty of Medicine, Ain Shams University Sub-Specialty General Adult, Adolescent and Addiction Psychiatry